CLINICAL_TRIALS
trial_result
· 2017-08-02
Clinical Trial Update: Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis [Phase 3]
Summary
Phase 3 trial update on subcutaneous abatacept for active psoriatic arthritis reports efficacy and safety findings.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-08-02